Cardiomyopathy, long associated with adults following injury or aging, has recently moved to the forefront of the pediatric population. Improved repair of cardiac birth defects, as well as enhanced treatment of acute cardiac injury in the pediatric population has led to increases in the incidence of cardiomyopathy in the young. Cardiomyopathy is the leading reason for transplantation in the young, and the mortality and transplant rate after 2-years is 40% [1, 2, 3].

Cystic fibrosis (CF) is a life-threatening, inherited chronic disease that affects the lungs and digestive system of 30,000 children and adults in…

Synthetic particles are made in a plethora of flavors. The chemistry, crosslinking, particle size, and bioconjugated ligands are tuned over and…

Children with diabetes mellitus often fail to monitor their blood glucose concentration because of the fear, pain, and inconvenience associated…

Lung airway diseases are one of the major causes of infant mortality in the United States. Such diseases result in narrowing of airways,…

This project aims to identify therapeutic targets in pathogenic polymorphonuclear neutrophils (PMNs), an inflammatory subset that destroys airways…